These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25629516)

  • 1. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
    Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
    PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.
    Mantani PT; Dunér P; Ljungcrantz I; Nilsson J; Björkbacka H; Fredrikson GN
    BMC Immunol; 2019 Dec; 20(1):47. PubMed ID: 31823769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
    Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
    Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
    J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
    Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
    Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
    Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
    Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet.
    Jeon US; Choi JP; Kim YS; Ryu SH; Kim YK
    Exp Mol Med; 2015 May; 47(5):e163. PubMed ID: 25976521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice.
    Mantani PT; Dunér P; Bengtsson E; Ljungcrantz I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
    J Biol Chem; 2018 May; 293(18):6791-6801. PubMed ID: 29572351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
    Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E
    Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
    Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
    Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.
    Perry HM; Oldham SN; Fahl SP; Que X; Gonen A; Harmon DB; Tsimikas S; Witztum JL; Bender TP; McNamara CA
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2771-9. PubMed ID: 24115031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
    Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
    Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
    Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
    Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
    Dietrich T; Hucko T; Schneemann C; Neumann M; Menrad A; Willuda J; Atrott K; Stibenz D; Fleck E; Graf K; Menssen HD
    Atherosclerosis; 2012 Feb; 220(2):329-36. PubMed ID: 22062588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Davenport P; Tipping PG
    Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.